This is not the most recent version of the article. View current version (15 DEC 2014)

Intervention Review

Ursodeoxycholic acid for cystic fibrosis-related liver disease

  1. Katharine Cheng1,*,
  2. Deborah Ashby2,
  3. Rosalind L Smyth3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 17 OCT 2012

Assessed as up-to-date: 12 SEP 2012

DOI: 10.1002/14651858.CD000222.pub2


How to Cite

Cheng K, Ashby D, Smyth RL. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD000222. DOI: 10.1002/14651858.CD000222.pub2.

Author Information

  1. 1

    Institute of Child Health, University of Liverpool, c/o Cochrane Cystic Fibrosis & Genetic Disorders Review Group, Liverpool, UK

  2. 2

    Imperial College London, School of Public Health, London, UK

  3. 3

    UCL, Institute of Child Health, London, UK

*Katharine Cheng, c/o Cochrane Cystic Fibrosis & Genetic Disorders Review Group, Institute of Child Health, University of Liverpool, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, L12 2AP, UK. nikkij@liv.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2012

SEARCH

This is not the most recent version of the article. View current version (15 DEC 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mark P. Murphy, Emma Caraher, Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms, Drugs in R&D, 2016,

    CrossRef

  2. 2
    Charlotte Addy, Damian G Downey, J Stuart Elborn, Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century, Expert Opinion on Orphan Drugs, 2016, 4, 1, 5

    CrossRef

  3. 3
    Thomas Kelly, James Buxbaum, Gastrointestinal Manifestations of Cystic Fibrosis, Digestive Diseases and Sciences, 2015, 60, 7, 1903

    CrossRef

  4. 4
    Oren Ledder, Wolfram Haller, Richard TL Couper, Peter Lewindon, Mark Oliver, Cystic fibrosis: An update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations, Journal of Gastroenterology and Hepatology, 2014, 29, 12
  5. 5
    Lisette Leeuwen, Dominic A. Fitzgerald, Kevin J. Gaskin, Liver Disease in Cystic Fibrosis, Paediatric Respiratory Reviews, 2014, 15, 1, 69

    CrossRef

  6. 6
    Donna McShane, Liver disease in cystic fibrosis, Paediatrics and Child Health, 2013, 23, 12, 526

    CrossRef